Nilotinib 150 Mg · Strip

Tasigna 150 Mg Capsules

Rx (Prescription Medicine)

USD $ 756.00

USD $ 27.00 per unit

Upload prescription Ask about this medicine
  • Dispatched from licensed pharmacy partners
  • Tracked worldwide shipping
  • Secure payment

Select pack size

Key facts

Active ingredient
Nilotinib
Strength
150 Mg
Form
Capsule
Drug class
Generic
Brand
Tasigna
Manufacturer
Novartis India
Pack sizes
84 Capsules, 28 Capsules, 56 Capsules

Description

Tasigna 150mg Tablets are manufactured by Novartis India Ltd in Switzerland and contain 150mg of Nilotinib per tablet. Each Bottle includes 4 Capsules in a Strip making Tasigna 150mg Tablets an effective option for Blood Cancer. Prescription Required from your healthcare provider to purchase Nilotinib medicine. Indogenmed deals in all types of generic Nilotinib medicine

Additional information

Brand Name

Pack Quantity

84 Capsules, 28 Capsules, 56 Capsules

Country Of Origin

Switzerland

Medicine Form

Capsule

Medicine Type

Generic

Molecule

Packaging Type

Strip

Rx Status

Rx (Prescription Medicine)

Strength

150 Mg

0.00

1 verified review

1 review for Tasigna 150 Mg Capsules

  1. Avatar of James Young

    James Young

    Review from OpenCart migration

Only logged in customers who have purchased this product may leave a review.

Same molecule & strength

Other brands of Nilotinib 150 Mg — the same active ingredient at the same strength, from a different manufacturer.

On this page
  1. Key facts
  2. Description
  3. Additional information
  4. Reviews (1)
  5. Same molecule

Content integrity

Medically reviewed by

Renu Meena, B.Pharm

Medical Content Writer

Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Last reviewed 13/07/2026

Shipping to your country

Options
Fast Delivery – Arrives in 7–12 Days, Standard Delivery – Arrives in 12–20 Days
Free over
USD $ 200.00